DaVita Future Growth
Future criteria checks 1/6
DaVita's earnings are forecast to decline at 4.7% per annum while its annual revenue is expected to grow at 3.6% per year. EPS is expected to grow by 3.8% per annum. Return on equity is forecast to be 139.5% in 3 years.
Key information
-4.7%
Earnings growth rate
3.8%
EPS growth rate
Healthcare earnings growth | 19.3% |
Revenue growth rate | 3.6% |
Future return on equity | 139.5% |
Analyst coverage | Good |
Last updated | 29 Aug 2024 |
Recent future growth updates
Recent updates
DaVita (NYSE:DVA) Has A Pretty Healthy Balance Sheet
Jul 02Is There Now An Opportunity In DaVita Inc. (NYSE:DVA)?
Jun 19Are DaVita Inc. (NYSE:DVA) Investors Paying Above The Intrinsic Value?
Jun 04Returns On Capital At DaVita (NYSE:DVA) Have Hit The Brakes
May 22DaVita Stock Is A Hold As It Expands In Latin America
Mar 18Market Might Still Lack Some Conviction On DaVita Inc. (NYSE:DVA) Even After 27% Share Price Boost
Mar 13Is There Now An Opportunity In DaVita Inc. (NYSE:DVA)?
Mar 04DaVita Inc. (NYSE:DVA) Analysts Are Pretty Bullish On The Stock After Recent Results
Feb 16Is DaVita (NYSE:DVA) Using Too Much Debt?
Feb 08DaVita: Assessing After The Rally
Dec 29DaVita Inc.'s (NYSE:DVA) Subdued P/E Might Signal An Opportunity
Dec 24DaVita (NYSE:DVA) Has A Somewhat Strained Balance Sheet
Nov 08DaVita: Simple And Compelling After Sell-Off
Oct 26Returns On Capital Signal Difficult Times Ahead For DaVita (NYSE:DVA)
Oct 25DaVita: Continued Economic Hurdles, Market Expectations May Be Correct
Oct 05Is It Too Late To Consider Buying DaVita Inc. (NYSE:DVA)?
Aug 14DaVita (NYSE:DVA) Takes On Some Risk With Its Use Of Debt
Jul 31DaVita: Breakout Not Supported Without Leverage Effects, Reiterate Hold
Jul 21Returns At DaVita (NYSE:DVA) Appear To Be Weighed Down
Jul 18DaVita Inc. (NYSE:DVA) Shares Could Be 41% Below Their Intrinsic Value Estimate
Jul 03What Is DaVita Inc.'s (NYSE:DVA) Share Price Doing?
May 01These 4 Measures Indicate That DaVita (NYSE:DVA) Is Using Debt Extensively
Apr 17Investors Met With Slowing Returns on Capital At DaVita (NYSE:DVA)
Apr 03Are Investors Undervaluing DaVita Inc. (NYSE:DVA) By 40%?
Mar 08DaVita HealthCare Partners Q4 2022 Earnings Preview
Feb 21Moon Capital - DaVita: A Recession-Resistant Cash Generating Machine
Feb 08Is Now The Time To Look At Buying DaVita Inc. (NYSE:DVA)?
Jan 24Is DaVita (NYSE:DVA) A Risky Investment?
Jan 09DaVita: Shares Still Appear Cheap After Outlook Cut, Technicals Suggest Caution
Dec 12DaVita Q3 2022 Earnings Preview
Oct 27Is Now The Time To Look At Buying DaVita Inc. (NYSE:DVA)?
Oct 18DaVita: Solid Valuation And Cash Flow, Price Recovering After SCOTUS Ruling
Sep 28DaVita could benefit from legislation that would return dialysis protection to Medicare
Aug 16We Think DaVita (NYSE:DVA) Is Taking Some Risk With Its Debt
Aug 14DaVita stock dips as peer Fresenius outlook weighed down by labor cost, inflation
Jul 28DaVita: Valuation Turning Attractive
Jul 16Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 13,681 | 705 | N/A | N/A | 3 |
12/31/2025 | 13,286 | 847 | N/A | N/A | 7 |
12/31/2024 | 12,741 | 809 | 855 | N/A | 7 |
6/30/2024 | 12,524 | 860 | 1,269 | 1,810 | N/A |
3/31/2024 | 12,338 | 816 | 920 | 1,462 | N/A |
12/31/2023 | 12,140 | 692 | 1,491 | 2,059 | N/A |
9/30/2023 | 11,911 | 596 | 1,314 | 1,918 | N/A |
6/30/2023 | 11,739 | 454 | 1,357 | 1,967 | N/A |
3/31/2023 | 11,665 | 500 | 1,077 | 1,705 | N/A |
12/31/2022 | 11,610 | 547 | 961 | 1,565 | N/A |
9/30/2022 | 11,637 | 680 | 1,152 | 1,751 | N/A |
6/30/2022 | 11,627 | 834 | 995 | 1,607 | N/A |
3/31/2022 | 11,616 | 903 | 1,479 | 2,099 | N/A |
12/31/2021 | 11,619 | 978 | 1,289 | 1,931 | N/A |
9/30/2021 | 11,580 | 984 | 1,209 | 1,886 | N/A |
6/30/2021 | 11,566 | 883 | 1,124 | 1,802 | N/A |
3/31/2021 | 11,529 | 791 | 1,108 | 1,773 | N/A |
12/31/2020 | 11,551 | 783 | 1,304 | 1,979 | N/A |
9/30/2020 | 11,544 | 832 | 1,506 | 2,175 | N/A |
6/30/2020 | 11,524 | 824 | 1,648 | 2,333 | N/A |
3/31/2020 | 11,487 | 816 | 2,112 | 2,834 | N/A |
12/31/2019 | 11,388 | 705 | 1,730 | 2,496 | N/A |
9/30/2019 | 11,311 | 623 | 1,406 | 2,235 | N/A |
6/30/2019 | 11,253 | 548 | 1,124 | 2,011 | N/A |
3/31/2019 | 11,300 | 551 | 255 | 1,208 | N/A |
12/31/2018 | 11,412 | 616 | 544 | 1,531 | N/A |
9/30/2018 | 11,378 | 617 | 621 | 1,592 | N/A |
6/30/2018 | 11,299 | 698 | 698 | 1,679 | N/A |
3/31/2018 | 11,110 | 652 | N/A | 1,470 | N/A |
12/31/2017 | 10,884 | 909 | N/A | 1,966 | N/A |
9/30/2017 | 7,773 | 1,065 | N/A | 1,983 | N/A |
6/30/2017 | 8,732 | 1,480 | N/A | 2,016 | N/A |
3/31/2017 | 9,747 | 1,382 | N/A | 2,391 | N/A |
12/31/2016 | 10,696 | 1,038 | N/A | 1,988 | N/A |
9/30/2016 | 14,550 | 716 | N/A | 1,918 | N/A |
6/30/2016 | 14,347 | 361 | N/A | 2,061 | N/A |
3/31/2016 | 14,065 | 478 | N/A | 1,576 | N/A |
12/31/2015 | 9,973 | 323 | N/A | 1,531 | N/A |
9/30/2015 | 13,565 | 484 | N/A | 1,051 | N/A |
6/30/2015 | 13,290 | 452 | N/A | 1,219 | N/A |
3/31/2015 | 13,027 | 429 | N/A | 1,450 | N/A |
12/31/2014 | 12,781 | 723 | N/A | 1,459 | N/A |
9/30/2014 | 12,519 | 727 | N/A | 1,884 | N/A |
6/30/2014 | 12,270 | 680 | N/A | 1,769 | N/A |
3/31/2014 | 11,971 | 787 | N/A | 1,813 | N/A |
12/31/2013 | 11,759 | 620 | N/A | 1,773 | N/A |
9/30/2013 | 11,174 | 564 | N/A | 1,619 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DVA's earnings are forecast to decline over the next 3 years (-4.7% per year).
Earnings vs Market: DVA's earnings are forecast to decline over the next 3 years (-4.7% per year).
High Growth Earnings: DVA's earnings are forecast to decline over the next 3 years.
Revenue vs Market: DVA's revenue (3.6% per year) is forecast to grow slower than the US market (8.7% per year).
High Growth Revenue: DVA's revenue (3.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: DVA's Return on Equity is forecast to be very high in 3 years time (139.5%).